Search
Neurogene Inc
NGNEAdd to Watchlist
32.890USD
-0.710-2.11%
Close 07-31 16:00（ET）Quotes delayed by 15 min
649.27MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Samsara BioCapital, LLC
10.87%
Redmile Group, LLC
9.24%
RTW Investments L.P.
8.62%
McMinn (Rachel L.)
8.24%
Casdin Capital, LLC
8.20%
Other
54.83%
Shareholders
Shareholders
Proportion
Samsara BioCapital, LLC
10.87%
Redmile Group, LLC
9.24%
RTW Investments L.P.
8.62%
McMinn (Rachel L.)
8.24%
Casdin Capital, LLC
8.20%
Other
54.83%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
39.55%
Hedge Fund
26.47%
Investment Advisor
18.98%
Venture Capital
12.24%
Research Firm
9.42%
Individual Investor
8.94%
Sovereign Wealth Fund
2.35%
Bank and Trust
0.10%
Pension Fund
0.06%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
225
17.70M
113.37%
-1.04M
2025Q4
214
16.75M
108.11%
-2.07M
2025Q3
202
15.71M
110.06%
-3.24M
2025Q2
207
17.85M
125.13%
-2.21M
2025Q1
216
18.11M
126.54%
-1.93M
2024Q4
211
17.68M
118.99%
+934.89K
2024Q3
193
15.29M
117.57%
+50.95K
2024Q2
185
14.71M
113.65%
+656.15K
2024Q1
190
13.87M
122.85%
+4.51M
2023Q4
186
10.89M
99.88%
+9.09M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Samsara BioCapital, LLC
1.72M
11.03%
--
--
Dec 31, 2025
Redmile Group, LLC
1.46M
9.37%
+160.58K
+12.36%
Dec 31, 2025
RTW Investments L.P.
1.36M
8.75%
--
--
Dec 31, 2025
McMinn (Rachel L.)
1.27M
8.17%
-3.35K
-0.26%
Mar 26, 2026
Casdin Capital, LLC
1.30M
8.32%
--
--
Dec 31, 2025
EcoR1 Capital, LLC
1.27M
8.16%
--
--
Dec 31, 2025
Baker Bros. Advisors LP
991.69K
6.37%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
825.00K
5.3%
+31.54K
+3.97%
Dec 31, 2025
Trails Edge Capital Partners LP
785.00K
5.04%
+785.00K
--
Dec 31, 2025
TD Securities, Inc.
681.34K
4.37%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1.14%
iShares Neuroscience and Healthcare ETF
0.42%
Franklin Genomic Advancements ETF
0.21%
iShares Micro-Cap ETF
0.06%
Invesco Nasdaq Biotechnology ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.05%
ProShares Ultra Nasdaq Biotechnology
0.04%
iShares Biotechnology ETF
0.04%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 Value ETF
0.01%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.14%
iShares Neuroscience and Healthcare ETF
Proportion0.42%
Franklin Genomic Advancements ETF
Proportion0.21%
iShares Micro-Cap ETF
Proportion0.06%
Invesco Nasdaq Biotechnology ETF
Proportion0.05%
Fidelity Enhanced Small Cap ETF
Proportion0.05%
ProShares Ultra Nasdaq Biotechnology
Proportion0.04%
iShares Biotechnology ETF
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.03%
iShares Russell 2000 Value ETF
Proportion0.01%